Table 1.
Author, year | Geographic location | Study design (data source) | Study period (total duration in years with follow up) | Population | No. of patients | Definition of cases | No. of PsA patients | Comparison group | Mean age, years | Female (%) |
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
All- cause mortality | ||||||||||
Wilson et al. 2009 [20] | Olmsted Country, USA | Population-based, retrospective cohort (Rochester epidemiology project) | 1970–1999 (29) | 18+ | 124,277 | CASPAR | 147 | General Population | 42.7 +/− 15.2 | 39 |
Buckley et al. 2010 [29] | Bath, UK | Retrospective cohort, single center (National death registry/NHS strategic tracing service) | 1985–2007 (23) | 18+ | 453 | Moll and Wright/CASPAR | 453 | General population | 49 | 48.8 |
Mok et al. 2011 [22] | Hong Kong, China | Population- Based, Retrospective cohort (CDARS - outpatient clinics and inpatient admissions) | 1999–2008 (9) | NR | 18627 | ICD-9 | 778 | General population | 51.7 +/− 13.2 | 46 |
Ogdie et al. 2014 [18] | UK | Population-based, longitudinal cohort study (THIN database) | 1994–2010 (16) | 18+ | 132031 | READ Code | 8706 | General Population /Rheumatoid Arthritis | 50.54 | 48.9 |
Juneblad et al. 2016 [28] | Västerbotten County, Sweden | Retrospective, referral cohort (National death registry) | 1995–2011 (16) | 18+ | 464 | CASPAR ICD-9 | 464 | General Population | 59.5 | 49.6 |
Dai et al. 2018 [24] | Taiwan | Nationwide, population-based cohort (National Health Insurance) | 2000–2001 (12) | 18+ | 106701 | CASPAR, ICD-9 | 8795 | General Population, Psoriasis | 45.1 | 40.5 |
Skov et al. 2019 [23] | Denmark | Nationwide, population-based, retrospective Cohort (National patient registry) | 1998–2014 (16) | 18+ | 21,977 | ICD-10 | 9817 | General Population | 49.6 | 48.8 |
Elalouf et al. 2020 [22] | Toronto, Canada | Prospective, specialty clinic cohort (University of Toronto PsA clinic) | 1978–2017 (39) | 18+ | 1490 | CASPAR, ICD-9, ICD10 | 1490 | General Population | 45.5 | 44 |
Colaco et al.2020 [17] | Ontario, Canada | Population-based, retrospective cohort (Ontario Health Insurance databases) | 2008–2016 (20) | 20+ | 192288 | Validated admistrative case definitions | 15430 | General Population | - | - |
Karmacharya et al. 2021 [21] | Olmsted County, MN, USA | Population-based, retrospective cohort (Rochester epidemiology project) | 2000–2017 (19) | 18+ | 484 | CASPAR | 164 | General Population | 46.4 (±12.0) | 47% |
Cardiovascular mortality | ||||||||||
Juneblad et al. 2016 [28] | Västerbotten County, Sweden | Retrospective, referral cohort (National death registry) | 1995–2005 (16) | 18+ | 464 | CASPAR, ICD 9 | 464 | General Population | 59.5 | 49.6 |
Ogdie et al. 2017 [19] | United Kingdom | Population-based, longitudinal cohort (THIN database) | 1994–2010 (16) | 18+ | 132031 | READ code | 8706 | General Population/ Rheumatoid Arthritis | 50.54 | 48.9 |
Skov et al. 2019 [23] | Denmark | Population-based, retrospective cohort (National patient registry) | 1998–2014 (16) | 18+ | 21977 | ICD-10 | 9817 | General Population | 49.6 | 48.8 |
Elalouf et al. 2020 [22] | Toronto, Canada | Prospective, specialty center cohort (University of Toronto PsA clinic) | 1978–2017 (39) | 18+ | 1490 | CASPAR, ICD-9, ICD-10 | 1490 | General Population | 45.5 | 44 |
Colaco et al. 2020 [17] | Ontario,Canada | Population-based, retrospective Cohort (Ontario Health Insurance databases) | 2008–2016 (20) | 20+ | 192288 | Validated admistrative case definitions | 15430 | General Population | - | - |
Respiratory disease-related mortality | ||||||||||
Ogdie et al. 2017 [19] | United Kingdom | Population-based, longitudinal cohort (THIN database) | 1994–2010 (16) | 18+ | 132031 | READ Code | 8706 | General Population/ Rheumatoid Arthritis | 50.54 | 48.9 |
Skov et al. 2019 [23] | Denmark | Population-based, retrospective cohort (National patient registry) | 1998–2014 (16) | 18+ | 21977 | ICD-10 | 9817 | General Population | 49.6 | 48.8 |
Elalouf et al. 2020 [22] | Toronto, Canada | Prospective, specialty center cohort (University of Toronto PsA clinic) | 1978–2017 (39) | 18+ | 1490 | CASPAR, ICD-9, ICD-10 | 1490 | General Population | 45.5 | 44 |
Colaco et al. 2020 [17] | Ontario, Canada | Population-based, retrospective cohort (Ontario Health Insurance databases) | 2008–2016 (20) | 20+ | 192288 | Validated admistrative case definitions | 15430 | General Population | - | - |
Infection and malignancy related mortality | ||||||||||
Juneblad et al. 2016 [28]* | Västerbotten County, Sweden | Retrospective, referral cohort (National death registry) | 1995–2005 (16) | 18+ | 464 | CASPAR ICD 9 | 464 | General Population | 59.5 | |
Ogdie et al. 2017 [19] | UK | Population-based, longitudinal Cohort (THIN database) | 1994–2010 (16) | 18+ | 132031 | READ Code | 8706 | General Population/ Rheumatoid Arthritis | 50.54 | 48.9 |
Skov et al. 2019 [23] | Denmark | Population-based, retrospective cohort (National patient registry) | 1998–2014 (16) | 18+ | 21977 | ICD-10 | 9817 | General Population | 49.6 | 48.8 |
Elalouf et al. 2020 [22] | Toronto, Canada | Prospective, specialty center cohort (University of Toronto PsA clinic) | 1978–2017 (39) | 18+ | 1490 | CASPAR, ICD-9, ICD-10 | 1490 | General Population | 45.5 | 44 |
Colaco et al. 2020 [17] | Ontario, Canada | Population-based, retrospective cohort (Ontario Health) | 2008–2016 (20) | 20+ | 192288 | Validated administrative case definitions | 15430 | General Population | - | - |
ICD= International Classification of Disease, CASPAR=-Classification Criteria for Psoriatic Arthritis, THIN= The Health Improvement Network, CDARS= Clinical Data Analysis and Reporting System, NR= not reported.
not included for infections related mortality